Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.33 |
| ▸ | UGT2B17 | O75795 | 2/20 | 0.31 |
| ▸ | EBP | Q15125 | 2/20 | 0.30 |
| ▸ | DHCR7 | Q9UBM7 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL819838 | 0.98 | HRH3 (0.33) | HRH3ALDH1A1POLBMAPTHTT | |
| SCHEMBL16213941 | 0.85 | NPSR1 (0.39) | ALDH1A1POLBMAPTHTTNPSR1 | |
| SCHEMBL920182 | 0.80 | TAS1R3 (0.36) | HRH3ALDH1A1POLBMAPTHTT | |
| SCHEMBL10029427 | 0.79 | HRH3 (0.37) | HRH3ALDH1A1POLBMAPTHTT | |
| SCHEMBL22223017 | 0.76 | HRH3 (0.39) | HRH3ALDH1A1POLBMAPTHTT | |
| SCHEMBL19944960 | 0.76 | ALDH1A1 (0.36) | HRH3ALDH1A1POLBMAPTHTT | |
| Hydrochloric Acid SCHEMBL1082120 | 0.74 | ALDH1A1 (0.35) | HRH3ALDH1A1POLBMAPTHTT | |
| SCHEMBL10035307 | 0.74 | SLC6A2 (0.36) | ALDH1A1MAPTNPSR1 | |
| SCHEMBL14578492 | 0.74 | SLC6A2 (0.36) | ALDH1A1MAPTNPSR1 | |
| SCHEMBL18643566 | 0.74 | SLC6A2 (0.36) | ALDH1A1MAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3795606-B1 | PROCESS FOR PREPARATION OF BLOCK COPOLYMER | LG CHEMICAL LTD (KR) | 2024-02-28 | — | — | EP | disclosed |
| US-11840604-B2 | Process for preparation of block copolymer | LG CHEM, LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| EP-3795607-B1 | TRIBLOCK COPOLYMER AND PREPARATION METHOD THEREFOR | LG CHEMICAL LTD (KR) | 2022-06-22 | — | — | EP | disclosed |
| US-20210309800-A1 | PROCESS FOR PREPARATION OF BLOCK COPOLYMER | LG CHEM, LTD. (KR) | 2021-10-07 | — | — | US | disclosed |
| EP-3795607-A1 | TRIBLOCK COPOLYMER AND PREPARATION METHOD THEREFOR | LG CHEM, LTD. (KR) | 2021-03-24 | — | — | EP | disclosed |
| WO-2020197147-A1 | METHOD FOR PREPARATION OF BLOCK COPOLYMER | 주식회사 엘지화학 | 2020-10-01 | — | — | WO | disclosed |
| WO-2020197148-A1 | TRIBLOCK COPOLYMER AND PREPARATION METHOD THEREFOR | 주식회사 엘지화학 | 2020-10-01 | — | — | WO | disclosed |
| EP-2574187-B1 | SQUALANE AND ISOSQUALANE COMPOSITIONS AND METHODS FOR PREPARING THE SAME | AMYRIS INC (US) | 2019-09-11 | — | — | EP | disclosed |
| US-8586814-B2 | Squalane and isosqualane compositions and methods for preparing the same | Amyris, Inc. (US) | 2013-11-19 | — | — | US | disclosed |
| EP-2574187-A1 | SQUALANE AND ISOSQUALANE COMPOSITIONS AND METHODS FOR PREPARING THE SAME | Amyris Biotechnologies, Inc. (US) | 2013-04-03 | — | — | EP | disclosed |
| WO-2011146837-A1 | SQUALANE AND ISOSQUALANE COMPOSITIONS AND METHODS FOR PREPARING THE SAME | Amyris, Inc. (US) | 2011-11-24 | — | — | WO | disclosed |
| US-20110287988-A1 | SQUALANE AND ISOSQUALANE COMPOSITIONS AND METHODS FOR PREPARING THE SAME | EUAGORE, LLC | 2011-11-24 | — | — | US | disclosed |
| US-7173097-B2 | Metathesis-curable composition with a reaction control agent | KERR CORPORATION (US) | 2007-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110287988-A1 | SQUALANE AND ISOSQUALANE COMPOSITIONS AND METHODS FOR PREPARING THE SAME | SQLE, FDFT1, COASY | HRH3 4314/4885ALDH1A1 155/4885POLB 427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.